Separate names with a comma.
Bristol-Myers Squibb acquires Celgene for $74 billion. Celgene stock surges while BMY plunges. 2019 starts well for Celgene. More M&As are in...
Stryker makes a takeover offer for Boston Scientific. Will it succeed? Boston Scientific stock surges to a new 52-week high on the acquisition...
Anybody else hearing chatter within any of the larger Pharma shopping around. Hearing very promising results
InnoPharma, a subsidiary of Pfizer and Allergan reaches a settlement on Restasis patent. Out of the four contestants, Mylan, Teva and Akorn are...